Medicare Part D coverage · 1.2 · RxCUI 2644523

1.2 ML somatrogon-ghla 20 MG/ML Pen Injector [Ngenla]

Per the CMS 2026 Part D formulary file, 1.2 ML somatrogon-ghla 20 MG/ML Pen Injector [Ngenla] is covered by 21 Medicare Part D plans (0.4% of enrollable products), averaging Tier 3.9, with prior authorization required on 100% of covering formularies.

0.4%
Plan coverage
21
Plans covering
T3.9
Avg tier
100%
Prior auth required

Verify with CMS →

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.

What the CMS Formulary Data Shows for 1.2 ML somatrogon-ghla 20 MG/ML Pen Injector [Ngenla]

Per the CMS 2026 Part D formulary file, 1.2 ML somatrogon-ghla 20 MG/ML Pen Injector [Ngenla] (RxNorm concept RXCUI 2644523, generic name 1.2) appears on 15 distinct formulary files spanning 21 Medicare Part D plan offerings - 0.4% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 3.9.

Real-world access to 1.2 ML somatrogon-ghla 20 MG/ML Pen Injector [Ngenla] depends on utilization management as much as tier placement: 100% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 1.2 ML somatrogon-ghla 20 MG/ML Pen Injector [Ngenla] today.

Coverage Details

Formularies covering
15
Plans covering
21
Coverage rate
0.4%
Tier range
Tier 1 – Tier 5
Average tier
Tier 4, Non-Preferred

Restrictions

Prior authorization required
100% of formularies
Step therapy required
0% of formularies
Quantity limits
0% of formularies

Tier Distribution Across Plans

5 plans
Tier 1, Preferred Generic
16 plans
Tier 5, Specialty

Medicare Advantage Plans (MA-PD) Covering 1.2 ML somatrogon-ghla 20 MG/ML Pen Injector [Ngenla]

21 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
SeniorCare Complete (HMO D-SNP) South Country Health Alliance T1 Yes $0 MN
AbilityCare (HMO D-SNP) South Country Health Alliance T1 Yes $0 MN
Alameda Alliance Wellness (HMO D-SNP) Alameda Alliance FOR Health T1 Yes $0 CA
Mass General Brigham SCO (HMO D-SNP) Mass General Brigham Health Plan, Inc T1 Yes $0 MA
Mass General Brigham One Care (HMO D-SNP) Mass General Brigham Health Plan, Inc T1 Yes $0 MA
Troy Medicare (HMO) Troy Health, Inc. T5 Yes $0 NC
Troy Medicare for Dual-eligible Beneficiaries (HMO D-SNP) Troy Health, Inc. T5 Yes $0 NC
Contra Costa Health Care Plus (HMO D-SNP) Contra Costa County Medical Service DBA Contra Costa Health T5 Yes $0 CA
Keystone First VIP Choice (HMO D-SNP) Vista Health Plan, Inc. T5 Yes $0 PA
AmeriHealth Caritas VIP Care (HMO D-SNP) Vista Health Plan, Inc. T5 Yes $0 PA
First Choice VIP Care (HMO D-SNP) Select Health OF South Carolina, Inc. T5 Yes $0 SC
AmeriHealth Caritas VIP Care (HMO D-SNP) AmeriHealth Caritas VIP Next, Inc. T5 Yes $0 DE
AmeriHealth Caritas VIP Care Choice (HMO D-SNP) AmeriHealth Caritas VIP Next, Inc. T5 Yes $0 DE
AmeriHealth Caritas VIP Care (HMO D-SNP) Amerihealth Caritas Florida, Inc. T5 Yes $0 FL
AmeriHealth Caritas VIP Care (HMO D-SNP) Amerihealth Caritas Louisiana, Inc. T5 Yes $0 LA
AmeriHealth Caritas VIP Care (HMO D-SNP) Amerihealth Caritas North Carolina, Inc. T5 Yes $0 NC
AmeriHealth Caritas VIP Care (HMO D-SNP) Amerihealth Michigan, Inc. T5 Yes $0 MI
Mass General Brigham Advantage (PPO) Mass General Brigham Health Plan, Inc. T5 Yes $0 MA
Mass General Brigham Advantage Secure (HMO-POS) Mass General Brigham Health Plan, Inc. T5 Yes $62.00 MA
Mass General Brigham Advantage Premier (PPO) Mass General Brigham Health Plan, Inc. T5 Yes $79.70 MA
Show the next 1 plans
Mass General Brigham Advantage Signature (PPO) Mass General Brigham Health Plan, Inc. T5 Yes $147.20 MA

Frequently Asked Questions

Is 1.2 ML somatrogon-ghla 20 MG/ML Pen Injector [Ngenla] covered by Medicare Part D?

Yes, 1.2 ML somatrogon-ghla 20 MG/ML Pen Injector [Ngenla] is covered by 21 Medicare Part D plans (0.4% of all Part D formularies).

What tier is 1.2 ML somatrogon-ghla 20 MG/ML Pen Injector [Ngenla] on Medicare Part D plans?

1.2 ML somatrogon-ghla 20 MG/ML Pen Injector [Ngenla] averages Tier 3.9 across Part D plans, ranging from Tier 1 to Tier 5.

Does 1.2 ML somatrogon-ghla 20 MG/ML Pen Injector [Ngenla] require prior authorization?

100% of Part D formularies require prior authorization for 1.2 ML somatrogon-ghla 20 MG/ML Pen Injector [Ngenla]. Step therapy: 0%. Quantity limits: 0%.

Nationwide similar Part D drugs

Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare